These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 37315551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
    Agarwal A, Freund KB, Kumar A, Aggarwal K, Sharma D, Katoch D, Bansal R, Gupta V, OCTA Study Group.
    Retina; 2021 Apr 01; 41(4):774-783. PubMed ID: 32833410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outcomes of retinal pigment epithelial detachment in Vogt-Koyanagi-Harada disease: a longitudinal analysis.
    Zheng C, Wang K, Zhang M, Tao Q, Li X, Zhang X.
    BMC Ophthalmol; 2022 Nov 19; 22(1):446. PubMed ID: 36401187
    [Abstract] [Full Text] [Related]

  • 6. Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease.
    Tabl AA, Elsayed MA, Tabl MA.
    Eur J Ophthalmol; 2022 Nov 19; 32(6):3482-3488. PubMed ID: 35266801
    [Abstract] [Full Text] [Related]

  • 7. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Maruyama Y, Kishi S.
    Ophthalmic Surg Lasers Imaging; 2004 Nov 19; 35(3):239-42. PubMed ID: 15185793
    [Abstract] [Full Text] [Related]

  • 8. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
    Han YS, Shin KS, Lee WH, Kim JY.
    Ophthalmologica; 2018 Nov 19; 239(2-3):143-150. PubMed ID: 29339644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
    Reibaldi M, Russo A, Avitabile T, Uva MG, Franco L, Longo A, Toro MD, Cennamo G, Mariotti C, Neri P, Noci ND, Russo V.
    Retina; 2014 Mar 19; 34(3):490-6. PubMed ID: 23903795
    [Abstract] [Full Text] [Related]

  • 12. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C, Guenoun JM, Dhote R, Brézin A.
    Ocul Immunol Inflamm; 2005 Mar 19; 13(2-3):225-7. PubMed ID: 16019683
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
    Zhang C, Wang Y, Chen Y, Zhou H, Hong Q, Yu X, Ng TK, Cen LP.
    BMC Ophthalmol; 2023 May 05; 23(1):199. PubMed ID: 37147563
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y, Otani T, Kishi S.
    Am J Ophthalmol; 2007 Aug 05; 144(2):260-5. PubMed ID: 17533104
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.